These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 33082395)
21. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk. Öztürk AB; Çağlayan B Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945 [No Abstract] [Full Text] [Related]
23. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19. Choudhary S; Sreenivasulu K; Mitra P; Misra S; Sharma P Ann Lab Med; 2021 Mar; 41(2):129-138. PubMed ID: 33063674 [TBL] [Abstract][Full Text] [Related]
24. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768 [TBL] [Abstract][Full Text] [Related]
25. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Yamamoto M; Kiso M; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Takeda M; Kinoshita N; Ohmagari N; Gohda J; Semba K; Matsuda Z; Kawaguchi Y; Kawaoka Y; Inoue JI Viruses; 2020 Jun; 12(6):. PubMed ID: 32532094 [TBL] [Abstract][Full Text] [Related]
26. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Yang L; Han Y; Nilsson-Payant BE; Gupta V; Wang P; Duan X; Tang X; Zhu J; Zhao Z; Jaffré F; Zhang T; Kim TW; Harschnitz O; Redmond D; Houghton S; Liu C; Naji A; Ciceri G; Guttikonda S; Bram Y; Nguyen DT; Cioffi M; Chandar V; Hoagland DA; Huang Y; Xiang J; Wang H; Lyden D; Borczuk A; Chen HJ; Studer L; Pan FC; Ho DD; tenOever BR; Evans T; Schwartz RE; Chen S Cell Stem Cell; 2020 Jul; 27(1):125-136.e7. PubMed ID: 32579880 [TBL] [Abstract][Full Text] [Related]
28. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293 [TBL] [Abstract][Full Text] [Related]
29. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Li Y; Zhou W; Yang L; You R Pharmacol Res; 2020 Jul; 157():104833. PubMed ID: 32302706 [TBL] [Abstract][Full Text] [Related]
30. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511 [TBL] [Abstract][Full Text] [Related]
31. Host Polymorphisms May Impact SARS-CoV-2 Infectivity. Brest P; Refae S; Mograbi B; Hofman P; Milano G Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550 [TBL] [Abstract][Full Text] [Related]
33. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Mollica V; Rizzo A; Massari F Future Oncol; 2020 Sep; 16(27):2029-2033. PubMed ID: 32658591 [No Abstract] [Full Text] [Related]
34. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors. Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944 [TBL] [Abstract][Full Text] [Related]
35. COVID-19, ACE2, and the cardiovascular consequences. South AM; Diz DI; Chappell MC Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252 [TBL] [Abstract][Full Text] [Related]
36. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection. Labò N; Ohnuki H; Tosato G Cells; 2020 Jun; 9(7):. PubMed ID: 32629875 [TBL] [Abstract][Full Text] [Related]
37. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes. Robinson EL; Alkass K; Bergmann O; Maguire JJ; Roderick HL; Davenport AP J Mol Cell Cardiol; 2020 Oct; 147():88-91. PubMed ID: 32818486 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Meacci E; Garcia-Gil M; Pierucci F Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]